AVEO Pharma
AcquiredCambridge, United States · Founded 2003 · $53.0M raised
- Headquarters
- Cambridge, Massachusetts
- Employees
- 51–200
- Founded
- 2003
- Business Model
- B2B
- Total Funding
- $53.0M
- Last Round
- $53.0M Series DApr 2007
- Rounds
- 4
About
Oncology-focused biopharmaceutical company developing targeted medicines for cancer patients; subsidiary of LG Chem since 2023.
Summary
AVEO Pharma is a Biotech company based in Cambridge, United States, founded in 2003. It has raised $53.0M in total across 4 rounds, most recently a $53.0M Series D round in Apr 2007. Investors include Bessemer VP, Merlin BioMed Group and Biogen.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Nov 2022
Sign up to see all 7 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Biopharmaceutical services company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...